Company Name CardioDx
Mailing Address 600 Saginaw Drive Redwood City, CA 94063 USA
Company Description Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
Proceeds Purposes The funds will enable CardioDx to broaden the commercial use of Corus CAD, the only clinically validated blood test that uses age, sex and gene expression to measure the likelihood of obstructive coronary artery disease in symptomatic patients, as well as to augment the company’s research efforts to improve healthcare quality and efficiency through the development of additional genomic tests for coronary artery disease.